Navigation Links
Dynac III

ProductsDynac III
Company BD Diagnostic Systems
Item Dynac III
Features 
Description BD Dynac III is a general purpose centrifuge. Digitally precise variable speeds, microprocessor controlled, versatile rotor choices, user programmable: speed, RCF and time, 10 program (memory) settings.
Info BD Diagnostic Systems
Customer Service: (800) 675-0908

Related medicine products :

1. Ultrasonic Pachymeter UP-1000
2. Ultramatic RX Master PHOROPTOR Refracting Instrument - Minus Cylinder Black
3. Ultramatic RX Master PHOROPTOR Refracting Instrument - Plus Cylinder Black
4. Compact Ultrasonic Phacoemulsification System
5. Osher Ultra Fine Tying Forceps
6. Ultrazyme Enzymatic Cleaner
7. Ultra Thin Sheet
8. Ultra MD40 Super Pulse CO2 Surgical Laser
9. Ultra MD 60 Super Pulse CO2 Surgical Laser
10. Ultra MD 80 Super Pulse CO2 Surgical Laser
11. UltraPulse SurgiTouch CO2 Laser System
TAG: Dynac III
Indicated for procedures of the wrist, ankle, elbow, and other small joints, the,UltrAblator is effective for ablation of soft tissue and coagulation of bleeders,encountered during surgery.
...me anatomical configuration as the lunate bone, th... stability. The implant has a pair of suture holes...caphoid and triquetrum to provide temporary postop...m forms around the implant. The design of this imp...
The 3.0 mm Cannulated Screw can be used with or without threaded washer. Uses 1.1 mm threaded or non-threaded guide wire. , ,The Threaded Washer provides a recessed internal buttress which allows the
...Wrist System was the first wrist implant to simula...hen it has become the leading wrist implant in the... surgery, doctors remove scar tissue and destroyed...in place of the damaged wrist. Doctors stabilize t...
Medicine Products:
(Date:5/16/2008)...thyroid hormone readings, study says , ,...vitamin D and high levels of a hormone secreted by...epression in older adults, according to a new repo...sue of Archives of General Psychiatry , supports ..., depression and other psychiatric illnesses are l...
(Date:5/16/2008)...wswire/ -- This release is,being sent in a social ...he,National Cancer Institute, part of the NIH., N...an Society of Clinical,Oncology meeting in Chicago...n about 25 percent of patients with colon cancer a...lorectal cancers will be staged., * This new stud...
(Date:5/16/2008)...ASHINGTON, May 16 /PRNewswire-USNewswire/ -- More ...ans in the Greater Portland, Oregon and,Vancouver,...ntract as,Teamsters., "The Teamsters are pleased ...tract that gives them job protection and a secure ...nt Jim Hoffa., The workers, both full-time and pa...
(Date:5/16/2008)... Phase III clinical trial has found that the exper...ficantly delays cancer progression in patients wit...ned on other treatments. The study was led by Rob... Sloan-Kettering Cancer Center (MSKCC), who will p...g of the American Society for Clinical Oncology. ,...
Breaking Medicine News(10 mins):Health News:Low Vitamin D Tied to Depression in Older Adults 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:Drug fends off kidney cancer progression 2
...m made by Baba Ramdev that yoga can cure AIDS. He ...be prevented by using condoms. // While Yoga and r...ose who are HIV positive to be healthier, it would...or AIDS will be found through yoga in the next cou...
...hase out the use of trans fat in restaurants. Othe...ow suit. //According to Alice H. Lichtenstein, DSc...cy at the Friedman School of Nutrition Science and...n the right direction, but restaurateurs need to r...
...ion under her skin on her chest wall and doctors w...of inflammation. //Interrogation revealed that the...istletoethrice every week. This case study is p...edical Journal (BMJ). A 19th-century Austrian phi...
...and reliability of LASIK and LASEK has found no cl...ypes of laser eye// surgery. The study, led by a ...ublished in the December 2006 issue of the America... "Although there have been many studies of the sa...
Other Medicine News:Health News:Trans Fat Ban: Watch Saturated Fats and Calories Too 2Health News:Trans Fat Ban: Watch Saturated Fats and Calories Too 3Health News:Study Compares LASIK and LASEK Eye Surgery 2
(Date:5/16/2008)...tes Statistically Significant Reductions in Select... Abstract to be published in 2008 Proceedings of t...linical Oncology, SAN DIEGO, May 16 /PRNewswire-F... ANX ) announced today that, in a registrational ...d a statistically significant reduction,in general...
(Date:5/15/2008)...linical data highlight safety profile of BSI-201 i...ors -, BRISBANE, Calif., May 15 /- B...tical company developing novel cancer therapies,t...inhibitor, BSI-201, will,be presented at the 2008 ...ng in Chicago., Findings will be presented from t...
(Date:5/15/2008)... May 15 /- Schering-Plough,...he science and treatment of,chronic hepatitis C vi...m,several clinical studies with PEGINTRON(TM) (peg...) combination therapy, as well as boceprevir, the,...tor, will be presented at,the 39th annual Digestiv...
(Date:5/15/2008)...rland, May 15 /- Ergonex Pharma today...ministration (FDA) has,granted orphan drug designa...rterial hypertension (PAH). Terguride is currently...al in Europe., "The FDA,s grant of orphan drug de...ngthens our development program by offering regula...
Breaking Medicine Technology:ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Pelosi Members of Texas Delegation to Rally for Childrens Health Care in San Antonio Tomorrow 6553 1Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy 871 1Holiday Hand Safety 101 3A Hand Surgeons Offer Tips for a Safe Carving Season 6549 1Holiday Hand Safety 101 3A Hand Surgeons Offer Tips for a Safe Carving Season 6549 2FDA Approves the Allergy Treatment Zyrtec 28R 29 for Use Without a Prescription 6546 1FDA Approves the Allergy Treatment Zyrtec 28R 29 for Use Without a Prescription 6546 2FDA Approves the Allergy Treatment Zyrtec 28R 29 for Use Without a Prescription 6546 3FDA Approves the Allergy Treatment Zyrtec 28R 29 for Use Without a Prescription 6546 4
...mited,today announced results from a study publish...ion that suggest infusions of a novel,new drug, CS...olesterol) levels, may reduce the amount of plaque...t episode of acute,coronary syndrome (ACS). , CSL ...herosclerosis – Safety and Efficacy (ERASE) ...
...l in Valortim-Treated Animals, , PRINCETON, N.J. a...tCall/ -- Medarex, Inc. , a leading monoclonal,ant...held,biotechnology company dedicated to the develo...ed that Valortim(TM), a fully human,monoclonal ant...evention and treatment of anthrax infection, has b...
Other Medicine Technology:CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 2CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 8